Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sapp

Showing results (181-190 of 211) with videos related to

Pageof 22
Sort By:
The New England Journal of Medicine|November 16, 2010
Cardiac-resynchronization therapy for mild-to-moderate heart failureAnthony S L Tang, George A Wells, Mario Talajic, et al.
Cardiovascular Diabetology|October 10, 2024
The relationship between repeated measurements of HbA<sub>1c</sub> and risk of coronary events among the common haptoglobin phenotype groups: the Action for Health in Diabetes (Look AHEAD) studyA S Carew, R A Warren, M P Bancks, et al.
Circulation. Arrhythmia and Electrophysiology|March 16, 2017
Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure TrialJohn L Sapp, Ratika Parkash, George A Wells, et al.
Journal of Cardiovascular Electrophysiology|January 23, 2018
Mexiletine or catheter ablation after amiodarone failure in the VANISH trialMarc W Deyell, Christian Steinberg, Steve Doucette, et al.
Journal of the American College of Cardiology|March 30, 2019
Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricular ArrhythmiasWilliam G Stevenson, Usha B Tedrow, Vivek Reddy, et al.
Heart Rhythm|October 3, 2017
HRS Clinical Document Development Methodology Manual and Policies: Executive summaryJulia H Indik, Kristen K Patton, Marianne Beardsall, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 14, 2025
Reduction of false-positive results with biochemical second-tier testing for newborn screening of Pompe diseaseIbrahim T Khoja, Dawn S Peck, Dimitar K Gavrilov, et al.
Circulation. Arrhythmia and Electrophysiology|April 27, 2022
Intramural Needle Ablation for Refractory Premature Ventricular ContractionsSrinivas R Dukkipati, Tomofumi Nakamura, Ikutaro Nakajima, et al.
The Canadian Journal of Cardiology|February 25, 2014
Left ventricular lead position and outcomes in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT)Stephen B Wilton, Derek V Exner, Jeffrey S Healey, et al.
JACC. Clinical Electrophysiology|May 26, 2018
Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH TrialKathryn Coyle, Doug Coyle, Isabelle Nault, et al.
Pageof 22

Showing results (181-190 of 211) with videos related to

Sort By:
Pageof 22
The New England Journal of Medicine|November 16, 2010
Cardiac-resynchronization therapy for mild-to-moderate heart failureAnthony S L Tang, George A Wells, Mario Talajic, et al.
Cardiovascular Diabetology|October 10, 2024
The relationship between repeated measurements of HbA<sub>1c</sub> and risk of coronary events among the common haptoglobin phenotype groups: the Action for Health in Diabetes (Look AHEAD) studyA S Carew, R A Warren, M P Bancks, et al.
Circulation. Arrhythmia and Electrophysiology|March 16, 2017
Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure TrialJohn L Sapp, Ratika Parkash, George A Wells, et al.
Journal of Cardiovascular Electrophysiology|January 23, 2018
Mexiletine or catheter ablation after amiodarone failure in the VANISH trialMarc W Deyell, Christian Steinberg, Steve Doucette, et al.
Journal of the American College of Cardiology|March 30, 2019
Infusion Needle Radiofrequency Ablation for Treatment of Refractory Ventricular ArrhythmiasWilliam G Stevenson, Usha B Tedrow, Vivek Reddy, et al.
Heart Rhythm|October 3, 2017
HRS Clinical Document Development Methodology Manual and Policies: Executive summaryJulia H Indik, Kristen K Patton, Marianne Beardsall, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|October 14, 2025
Reduction of false-positive results with biochemical second-tier testing for newborn screening of Pompe diseaseIbrahim T Khoja, Dawn S Peck, Dimitar K Gavrilov, et al.
Circulation. Arrhythmia and Electrophysiology|April 27, 2022
Intramural Needle Ablation for Refractory Premature Ventricular ContractionsSrinivas R Dukkipati, Tomofumi Nakamura, Ikutaro Nakajima, et al.
The Canadian Journal of Cardiology|February 25, 2014
Left ventricular lead position and outcomes in the Resynchronization-Defibrillation for Ambulatory Heart Failure Trial (RAFT)Stephen B Wilton, Derek V Exner, Jeffrey S Healey, et al.
JACC. Clinical Electrophysiology|May 26, 2018
Cost Effectiveness of Ventricular Tachycardia Ablation Versus Escalation of Antiarrhythmic Drug Therapy: The VANISH TrialKathryn Coyle, Doug Coyle, Isabelle Nault, et al.
Pageof 22